<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30102938</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Human immunology</Title><ISOAbbreviation>Hum Immunol</ISOAbbreviation></Journal><ArticleTitle>Genetic association between HLA-G 14-bp polymorphism and diseases: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>724</StartPage><EndPage>735</EndPage><MedlinePgn>724-735</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.humimm.2018.08.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0198-8859(18)30637-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">HLA-G is an immune checkpoint molecule. Since a differential molecule expression has been reported even for healthy individuals, many studies have focused on polymorphisms at HLA-G regulatory regions, particularly the 3' untranslated region (3'UTR). The presence/absence of a 14-bp sequence was the first polymorphism described and it is the most studied in association between HLA-G and disorders.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we performed a systematic review and meta-analysis of all association studies published regarding the HLA-G 14-bp.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We verified association between 14-bp alleles and diseases in the following situations: (1) presence of 14-bp (insertion) conferred susceptibility to preeclampsia (child alleles evaluated) and systemic lupus erythematosus (OR&#x202f;=&#x202f;1.42; 95%CI&#x202f;=&#x202f;1.04-1.93; p&#x202f;=&#x202f;0.026 and OR&#x202f;=&#x202f;1.13; 95%CI&#x202f;=&#x202f;1.01-1.27, p&#x202f;=&#x202f;0.028); (2) 14-bp absence (deletion) was associated with increased risk to breast cancer (OR&#x202f;=&#x202f;1.23; 95%CI&#x202f;=&#x202f;1.06-1.43; p&#x202f;=&#x202f;0.006) and human Cytomegalovirus infection (OR&#x202f;=&#x202f;2.06; 95%CI&#x202f;=&#x202f;1.60-2.64; p&#x202f;&lt;&#x202f;0.0001); and (3) a risk association was observed between the group of reproductive disorders and the 14-bp insertion (OR&#x202f;=&#x202f;1.12; 95%CI&#x202f;=&#x202f;1.01-1.24; p&#x202f;=&#x202f;0.034).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Considering that others 14-bp associations were inconclusive and that other variation sites observed at HLA-G 3'UTR exhibit a proven role on post-transcriptional regulation of HLA-G expression, the complete 3'UTR segment should be analyzed in terms of disease susceptibility, instead of a single polymorphism.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Almeida</LastName><ForeName>Bibiana Sgorla</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Divis&#xe3;o de Imunologia Cl&#xed;nica, Departamento de Cl&#xed;nica M&#xe9;dica, Faculdade de Medicina de Ribeir&#xe3;o Preto (FMRP), Universidade de S&#xe3;o Paulo (USP), 14049-900 Ribeir&#xe3;o Preto, SP, Brazil; Laborat&#xf3;rio Multiusu&#xe1;rio de Estudos em Biologia, Centro de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Santa Catarina (UFSC), Florian&#xf3;polis, Brazil. Electronic address: bibiana.sgorla@ufsc.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muniz</LastName><ForeName>Yara Costa Netto</ForeName><Initials>YCN</Initials><AffiliationInfo><Affiliation>Departamento de Biologia Celular, Embriologia e Gen&#xe9;tica, Centro de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Santa Catarina (UFSC), Florian&#xf3;polis, Brazil. Electronic address: yara.muniz@ufsc.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prompt</LastName><ForeName>Alice Heidrich</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Departamento de Biologia Celular, Embriologia e Gen&#xe9;tica, Centro de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Santa Catarina (UFSC), Florian&#xf3;polis, Brazil. Electronic address: prompt.a@ufsc.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castelli</LastName><ForeName>Erick C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Departamento de Patologia, Faculdade de Medicina de Botucatu, Unesp - Univ. Estadual Paulista, 18618-970 Botucatu, SP, Brazil. Electronic address: castelli@fmb.unesp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendes-Junior</LastName><ForeName>Celso Teixeira</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Faculdade de Filosofia Ci&#xea;ncias e Letras de Ribeir&#xe3;o Preto (FFCLRP), Universidade de S&#xe3;o Paulo (USP), 14049-900 Ribeir&#xe3;o Preto, SP, Brazil. Electronic address: ctmendes@ffclrp.usp.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donadi</LastName><ForeName>Eduardo Antonio</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Divis&#xe3;o de Imunologia Cl&#xed;nica, Departamento de Cl&#xed;nica M&#xe9;dica, Faculdade de Medicina de Ribeir&#xe3;o Preto (FMRP), Universidade de S&#xe3;o Paulo (USP), 14049-900 Ribeir&#xe3;o Preto, SP, Brazil. Electronic address: eadonadi@fmrp.usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Immunol</MedlineTA><NlmUniqueID>8010936</NlmUniqueID><ISSNLinking>0198-8859</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020413">3' Untranslated Regions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059951">HLA-G Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020413" MajorTopicYN="N">3' Untranslated Regions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059951" MajorTopicYN="N">HLA-G Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054643" MajorTopicYN="N">INDEL Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016366" MajorTopicYN="N">Open Reading Frames</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012045" MajorTopicYN="N">Regulatory Sequences, Nucleic Acid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">14-bp polymorphism</Keyword><Keyword MajorTopicYN="N">3&#x2032;UTR</Keyword><Keyword MajorTopicYN="N">HLA-G</Keyword><Keyword MajorTopicYN="N">Indel</Keyword><Keyword MajorTopicYN="N">Non-classical MHC</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30102938</ArticleId><ArticleId IdType="doi">10.1016/j.humimm.2018.08.003</ArticleId><ArticleId IdType="pii">S0198-8859(18)30637-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>